Stenham Asset Management Ltd / MRTXEUR
Stenham Asset Management Ltd’s Mirati Therapeutics Inc Position
Does Stenham Asset Management Ltd own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 19.3K shares worth $3M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q3 2021
Shares
19.3K
% of Portfolio
+2.23%
Quarters Held
2
position exited
Position History MRTXEUR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stenham Asset Management Ltd’s full portfolio or all institutional holders of MRTXEUR.